Drug · DIN 02473550
ADDYI
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 2, 2026; first marketed November 13, 2018.
- Drug Identification Number (DIN)
- 02473550
- Company (DIN owner)
- Sprout Pharmaceuticals IncRaleigh, North Carolina, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Flibanserin G02CX02
- Class
- Human
- Record last updated
- July 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FLIBANSERIN | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 25, 2025: NOC 36430New Drug Submission (NDS) · Administrative: Change in product ownership
- October 2, 2020: NOC 24380New Drug Submission (NDS) · Change in product ownershp
- June 20, 2019: NOC 22314New Drug Submission (NDS) · Change in product ownership
- February 27, 2018: NOC 20529New Drug Submission (NDS)